We are monitoring the impact of COVID-19 on Genome Engineering Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 8455
Share on
Share on

Global Genome Engineering Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Technology, Application, End User and Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 8455
Pages: 170

Global Genome Engineering Market Size (2021 to 2026)

The size of the global genome engineering market is estimated to be worth USD 8.29 billion by 2026 from USD 4.19 billion in 2021, growing at a CAGR of 14.61% from 2021 to 2026.

The Genome Engineering market is a rapidly growing global market, which is mainly driven by the need for a solution for the current-day prevalence of unscrutinized diseases. Scientists from the Francis Crick Institute have discovered rules to determine the precision of CRISPR/Cas9 genome editing in human cells. These rules are expected to help improve the safety and efficiency of genome engineering in both clinics and labs.

The global genome editing and engineering market are mainly driven by the ease of the use of CRISPR technology for genome study and modifications, especially for the cell line engineering application. Also, the need for action to be taken against common cancers and infectious diseases is another primary driver to the growth of the global market.

However, the lack of research and development centers across the globe as they are required drags the growth of the global market in the mentioned forecast period. Also, the global concentration of the genome editing/engineering market in regions like North America and Europe reduces the chances of global market expansion into areas like Africa and the Middle East.




Market Size Available

2020 to 2026

Base Year


Forecast Period

2021 to 2026

Segments Covered

By Technology, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Market Leaders Profiled

Transposagen Biopharmaceuticals (US), Thermo Fisher Scientific (US), Editas Medicine, Inc. (US), Merck (Germany), Lonza Group (Switzerland), OriGene Technologies (US), Horizon Discovery Group (UK), Intellia Therapeutics, Inc. (US), GenScript (US), Sangamo BioSciences (US), Cellectis S.A. (France), Integrated DNA Technologies (US), Bluebird Bio, Inc. (US), New England Biolabs (US), Editas Medicine (US), Sigma-Aldrich Corporation (US), and CRISPR Therapeutics (Switzerland)


This research report on the Global Genome Engineering Market has been segmented & sub-segmented into the following categories and analyzed market size & forecast for each segment until 2026.

Genome Engineering Market - By Technology:

  • ZFN
  • Antisense
  • Others

Among the mentioned technologies, the CRISPR segment is anticipated to account for the largest share of the global market for genome editing. The exceptional growth is attributed to the convenient usage associated with this technology, along with its multiple capabilities.

Genome Engineering Market - By Application:

  • Cell Line Engineering
  • Animal Genetic Engineering
  • Plant Genetic Engineering
  • Others

Of the mentioned applications, the cell line engineering segment is projected to have the largest share in the forecast period and with the fastest growth rate among others. The growth is because industries are focusing on stem cell research as it has shown decent results in the recent past.

Genome Engineering Market - By End User:

  • Biotechnology & Pharmaceutical Companies
  • Contract Research Organizations
  • Academic & Research Institutes

The pharmaceutical and biotechnology companies segment is expected to have the highest growth rate in the forecast as mentioned earlier period due to the increase in the prevalent infectious diseases and cancer, which drive the research to prevent and cure these diseases across the world.

Genome Engineering Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American genome engineering market leads the global genome engineering market by both value and volume, as of 2020. The situation of all the market key players in this region is the main reason for its leading market position. This region is anticipated to have the highest growth rate in the projected forecast period.

The European genome engineering market is expected to stand second in accounting for the majority share in the global market during the forecast period. The presence of a considerable customer base in and around this region is helping in the growth of the Genome Engineering market in Europe. It makes this the fastest growing regional market in the projected forecast period. Also, the technological supremacy of Europe and North America over the rest of the world is the necessary condition that facilitates them to develop in this emerging field, creating an eye-catching performance in the global market.

The Asia Pacific genome engineering market is predicted to be the fastest-growing regional market in the global market during the forecast period. The locational advantages offered this region, such as ease of setup and cheap resources, and a large number of skilled populations is a significant reason for this region’s position in the global market. However, the lack of healthcare-related advancements and research initiatives in this region makes it only the third fastest-growing region

On the other hand, the Middle East & Africa, and Latin America regions, being in the low developing countries due to the contribution of low GDP countries, have fewer opportunities for market growth. Hence, the Genome Engineering Market grows at a slow pace in these regions.


By the end of 2020, Transposagen Biopharmaceuticals (US), Thermo Fisher Scientific (US), Editas Medicine, Inc. (the US), Merck (Germany), Lonza Group (Switzerland), OriGene Technologies (US), Horizon Discovery Group (UK), Intellia Therapeutics, Inc. (US), GenScript (US), Sangamo BioSciences (US), Cellectis S.A. (France), Integrated DNA Technologies (US), Bluebird Bio, Inc. (the US), New England Biolabs (US), Editas Medicine (US), Sigma-Aldrich Corporation (US), and CRISPR Therapeutics (Switzerland) are the leading shareholders of the global market for Genome Engineering. There is constant competition between these companies regarding the pricing and quality of the product. They are currently focused on providing expansion strategies to improve their market value and position.

Key Highlights:

  • The evaluation of the current product and services market and the future implications of the market.
  • Address the matter by better understanding the market through size estimates and CAGR analysis to forecast the future market.
  • More extensive segmentation to better understand the dynamics of the market at a minimal level by dividing the market into smaller segments.
  • Address the critical market challenges, drivers, and restraints to provide insights for gaining market share.
  • Porter’s Five Forces are used to analyze the factors responsible for the shaping of the industry as it is a result of the competitive environment.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Technology                 

                                5.1.1 Introduction           

                                5.1.2 ZFN            

                                5.1.3 CRISPR      

                                5.1.4 Antisense

                                5.1.5 TALEN       

                                5.1.6 Others      

                                5.1.7 Y-o-Y Growth Analysis, By Technology        

                                5.1.8 Market Attractiveness Analysis, By Technology      

                                5.1.9 Market Share Analysis, By Technology        

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Cell Line Engineering           

                                5.2.3 Animal Genetic Engineering            

                                5.2.4 Plant Genetic Engineering

                                5.2.5 Others      

                                5.2.6 Y-o-Y Growth Analysis, By Application         

                                5.2.7 Market Attractiveness Analysis, By Application       

                                5.2.8 Market Share Analysis, By Application        

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Biotechnology & Pharmaceutical Companies           

                                5.3.3 Contract Research Organizations   

                                5.3.4 Academic & Research Institutes    

                                5.3.5 Y-o-Y Growth Analysis, By End User             

                                5.3.6 Market Attractiveness Analysis, By End User           

                                5.3.7 Market Share Analysis, By End User             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Geographical Area

                                       By Technology

                                       By Application

                                       By End User

                                6.1.4  Market Attractiveness Analysis     

                                       By Geographical Area

                                       By Technology

                                       By Application

                                       By End User

                                6.1.5  Market Share Analysis      

                                       By Geographical Area

                                       By Technology

                                       By Application

                                       By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Transposagen Biopharmaceuticals                   

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Thermo Fisher Scientific                        

                8.3 Editas Medicine, Inc.                              

                8.4 Merck                           

                8.5 Lonza Group                              

                8.6 OriGene Technologies                           

                8.7  Horizon Discovery Group                     

                8.8 Intellia Therapeutics, Inc.                     

                8.9  GenScript                   

                8.10 Sangamo BioSciences                          

                8.11 Cellectis S.A.                            

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         


                a) List of Tables                

                b) List of Figures                              

  • Global,Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of by technology,by application,by end user, along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Genome Editing/Genome Engineering Market Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Genome Editing/Genome Engineering Market Market, By Technology, From 2021 to 2026 (USD Million)
  3. Global ZFN Market, By Region, From 2021 to 2026 (USD Million)
  4. Global CRISPR Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Antisense Market, By Region, From 2021 to 2026 (USD Million)
  6. Global TALEN Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Others Market, By Region, From 2021 to 2026 (USD Million)
  8. Global Genome Editing/Genome Engineering Market, By Application, From 2021 to 2026 (USD Million)
  9. Global Cell Line Engineering Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Animal Genetic Engineering Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Plant Genetic Engineering Market, By Region, From 2021 to 2026 (USD Million)
  12. Global Others Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Genome Editing/Genome Engineering Market Market, By End User, From 2021 to 2026 (USD Million)
  14. Global Biotechnology & Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Million)
  15. Global Contract Research Organizations Market, By Region, From 2021 to 2026 (USD Million)
  16. Global Academic & Research Institutes Market, By Region, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 4255

Click for Request Sample